MPs call for increased protections for vulnerable benefit claimants
A cross-party committee of MPs has called for greater protections for vulnerable benefit claimants after hundreds of cases of deaths and serious harms linked to safeguarding failures by welfare officials.
The work and pensions select committee said many of these cases, which include instances where claimants took their own lives, could have been prevented had the Department for Work and Pensions (DWP) discharged its responsibilities effectively.
It cited the cases of Errol Graham, a disabled man with a long history of mental illness, who starved to death in 2018 after his benefits were cut off, and Philippa Day, a mother wrongly deprived of disability benefits for months, who died in 2019 after taking an overdose.
In both instances, coroners identified failures by DWP officials to properly take into account the acute difficulties both claimants faced in engaging with a benefits system they had found to be alienating and unsupportive.
These high-profile cases, and the DWP's prioritisation of cost-cutting over 'genuine care and support' for vulnerable people in recent years, had 'sorely damaged' public and claimant trust in the system, the committee said.
It published testimonies from benefit claimants saying their interactions with the DWP made them anxious, stressed and traumatised. One said it felt as if 'a system that is meant to wrap its arms around us is strangling us'.
Social security policies such as benefit sanctions and deductions were too often misapplied to vulnerable claimants, the committee said, leaving those individuals facing substantial hardship and putting them at risk of harm.
The committee chair, Labour's Debbie Abrahams, said 'deep-rooted' cultural change in the DWP was desperately needed to improve its treatment of vulnerable claimants.
'That people continue to face harm after dealing with the DWP is a self-evident failure of safeguarding in the system,' she said. 'We heard evidence that the process of engaging with the DWP itself too often led to mental distress. Where this led to not being able to get financial support, many had paid the ultimate price.'
Since 2020 at least 240 internal DWP reviews have been carried out into deaths or cases of serious harms where actions or omissions by officials may have been a factor, the committee said. On nine occasions since 2013, coroners have issued the DWP with formal reports recommending action to prevent future claimant deaths.
However, the impact of DWP safeguarding deficiencies was not properly understood within the department, the committee concluded. 'We remain concerned that the true scale of deaths and serious harms of vulnerable claimants is currently unknown,' it said.
The committee called for an independent scrutiny body to be created to investigate serious safeguarding failures and take appropriate action, amid concerns that the DWP was 'marking its own homework' over cases it may have mishandled.
Sign up to Headlines UK
Get the day's headlines and highlights emailed direct to you every morning
after newsletter promotion
The committee recommended that a legal duty to safeguard vulnerable claimants should be imposed on the DWP. Although in the past ministers have resisted the suggestion, the work and pensions secretary, Liz Kendall, told MPs last November she was open to the idea.
'A statutory safeguarding duty would help to drive and embed culture change in the department, support the consistent delivery of safeguarding practices, and improve accountability should failures occur,' the committee said.
The chief executive of the charity Rethink Mental Illness, Mark Winstanley, said a statutory DWP safeguarding duty would improve accountability. 'For too long, vulnerable people living with mental illness have suffered devastating harm and lost their lives due to failures in the benefits system,' he said.
A DWP spokesperson said: 'This government is committed to protecting the people who use our services and fixing the broken welfare system we inherited so it works for those who need it. That's why we are currently consulting on a new safeguarding approach, and our reforms will improve people's lives and rebuild trust by establishing an approach that genuinely supports vulnerable people.
'As we deliver our plan for change, we encourage people to have their voices heard through our consultation so we can build a safeguarding approach that works better for all.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
42 minutes ago
- The Independent
Reeves announces £6 billion to provide millions of NHS tests and procedures
Rachel Reeves has announced a £6 billion investment to speed up tests and treatment within the NHS, after setting out huge year-on-year rises in the health service's budget. New scanners, ambulances and urgent treatment centres are among the things which the additional cash will pay for, with the aim of providing up to four million more tests and procedures over the next five years. The announcement comes after the Chancellor put NHS funding at the heart of her spending review on Wednesday, raising its budget in a move worth £29 billion a year. This comes, however, at the expense of other areas of public spending. The new £6 billion funding will help to meet the Government's target of reducing NHS waiting lists in England, the Chancellor claimed. 'Over a decade of underinvestment from the previous government put the NHS on its knees, with people across the country unable to get the care they need. We are investing in Britain's renewal, and we will turn that around,' Ms Reeves said. She added: 'Part of our record investment will deliver four million tests, scans and procedures, so hard-working people can get the healthcare they and their families need. 'There is no strong economy without a strong NHS, and we'll deliver on our Plan for Change to end the hospital backlog, improve living standards and get more money in people's pockets.' The latest spending commitment will help patients get access to diagnostic scans and treatment in places such as shopping centres and high streets, speeding up their diagnoses. The Government hopes this will help to cut NHS waiting lists, meeting Labour's goal of ensuring the health service carries out 92% of routine operations within 18 weeks. Health Secretary Wes Streeting said: 'Since taking office we have been relentless in our drive to cut waiting times for patients, delivering over 3.6 million extra elective care appointments and reducing the overall waiting list by over 200,000. 'The £6 billion investment we are announcing today will generate millions more vital diagnostic tests, scans and procedures for patients across the country.' On Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after giving the NHS a 3% annual increase in funding at the spending review. Some health leaders are, however, sceptical that the Government will meet its target, despite the funding boost provided at the spending review. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, warned 'difficult decisions will still need to be made as this additional £29 billion won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Sarah Woolnough, chief executive of the King's Fund charity, said: 'The Chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times, more GP appointments, and adequate mental health services and more can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.'
The Independent
an hour ago
- The Independent
NHS to receive £6bn to provide millions more tests and procedures, Reeves confirms
Rachel Reeves has pledged a £6bn investment aimed at accelerating tests and treatments within the NHS, following substantial year-on-year budget increases for the health service. The additional funding will facilitate new scanners, ambulances, and urgent treatment centres, with the goal of delivering up to four million more tests and procedures over the next five years. This announcement follows the chancellor's emphasis on NHS funding in her recent spending review, where she allocated an additional £29bn annually to the NHS budget. However, this increase comes at the expense of other areas of public spending. The £6bn boost is intended to support the Government's objective of reducing NHS waiting lists in England, according to the chancellor. 'Over a decade of underinvestment from the previous government put the NHS on its knees, with people across the country unable to get the care they need. We are investing in Britain's renewal, and we will turn that around,' Ms Reeves said. She added: 'Part of our record investment will deliver four million tests, scans and procedures, so hard-working people can get the healthcare they and their families need. 'There is no strong economy without a strong NHS, and we'll deliver on our Plan for Change to end the hospital backlog, improve living standards and get more money in people's pockets.' The latest spending commitment will help patients get access to diagnostic scans and treatment in places such as shopping centres and high streets, speeding up their diagnoses. The Government hopes this will help to cut NHS waiting lists, meeting Labour's goal of ensuring the health service carries out 92 per cent of routine operations within 18 weeks. Health Secretary Wes Streeting said: 'Since taking office we have been relentless in our drive to cut waiting times for patients, delivering over 3.6 million extra elective care appointments and reducing the overall waiting list by over 200,000. 'The £6bn investment we are announcing today will generate millions more vital diagnostic tests, scans and procedures for patients across the country.' On Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after giving the NHS a 3 per cent annual increase in funding at the spending review. Some health leaders are, however, sceptical that the Government will meet its target, despite the funding boost provided at the spending review. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, warned 'difficult decisions will still need to be made as this additional £29bn won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Sarah Woolnough, chief executive of the King's Fund charity, said: 'The chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times, more GP appointments, and adequate mental health services and more can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.'
Daily Mail
2 hours ago
- Daily Mail
UK Pharmaceutical industry at risk from government's 'sky-high' rebates system
The UK's status as a leader in medical research is at risk from 'sky-high and unpredictable' repayments pharmaceutical firms hand the Government, says an industry boss. Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry, said the rebate system – where firms repay money they make through selling medicines to the NHS – was sending 'a terrible message to international investors'. Rachel Reeves promised to support 'the UK's strengths in life sciences' and 'ensure patients get rapid access to the most clinically and cost-effective new technologies'. The Treasury plans to invest up to £520million in drug manufacturing in the next five years. Another £600million is earmarked for a health data research service to accelerate the discovery of new medicines. But Torbett said more was needed. 'Over the past decade, accounting for inflation, the NHS budget has grown by a third in real terms, while investment in the most rigorously cost-benefit-tested part of health spending – investment in the medicines needed to treat people – has fallen from around 11 per cent to 9 per cent of the health budget,' he added. And he attacked plans to increase what drug companies must repay from drug sales to 31.3 per cent, from 15.5 per cent. 'The sky-high and unpredictable payment rates send a terrible message to international investors when the UK is trying to position life sciences research and development as an engine for health and growth. For the sake of patients, the NHS and the economy, we need a commitment to bring these unsustainable rates down.'
